» Articles » PMID: 10889151

Identification of a Novel Bacterial Sequence Associated with Crohn's Disease

Overview
Specialty Gastroenterology
Date 2000 Jul 13
PMID 10889151
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Enteric microorganisms are implicated in the pathogenesis of Crohn's disease (CD), but no clear bacterial or viral species has been identified. In this study, representational difference analysis (RDA) was used to isolate DNA segments preferentially abundant in lamina propria mononuclear cells of lesional mucosa vs. adjacent uninvolved mucosa.

Methods: Two RDA-derived microbial sequences were isolated (I1 and I2) and identified as novel homologues of the ptxR and tetR bacterial transcription-factor families.

Results: Quantitative competitive polymerase chain reaction of paraffin-embedded intestinal specimens from 212 patients showed that I2 DNA was present in many CD colonic lesions (43%), but was infrequent in other colonic specimens (9% of ulcerative colitis lesions and 5% of non-inflammatory bowel disease diseases; P<0.0001). I2 was prevalent in ileal specimens, regardless of disease status (43%-54%). Enzyme-linked immunosorbent assay analysis of 150 individuals with an I2 glutathione-S-transferase fusion protein showed frequent immunoglobulin A seroreactivity in CD (54% of patients), but infrequent seroreactivity in patients with ulcerative colitis, other inflammatory enteric diseases, or normals (10%, 19%, and 4%, respectively; P<0.001 to 0.00001).

Conclusions: These findings relate CD to a novel lesion-localized and immunologically associated bacterial sequence, suggesting that the microorganism expressing the I2 gene product may be related to CD pathogenesis.

Citing Articles

Unraveling the Role of the Human Gut Microbiome in Health and Diseases.

Khalil M, Di Ciaula A, Mahdi L, Jaber N, Di Palo D, Graziani A Microorganisms. 2024; 12(11).

PMID: 39597722 PMC: 11596745. DOI: 10.3390/microorganisms12112333.


Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond.

Hong S, Baek D Diagnostics (Basel). 2024; 14(13).

PMID: 39001273 PMC: 11241288. DOI: 10.3390/diagnostics14131384.


The Role of Biomarkers in Surgery for Ulcerative Colitis: A Review.

Matson J, Ramamoorthy S, Lopez N J Clin Med. 2021; 10(15).

PMID: 34362144 PMC: 8348722. DOI: 10.3390/jcm10153362.


Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 5: suitability of taxonomic units notified to EFSA until September 2016.

Ricci A, Allende A, Bolton D, Chemaly M, Davies R, Girones R EFSA J. 2020; 15(3):e04663.

PMID: 32625420 PMC: 7328882. DOI: 10.2903/j.efsa.2017.4663.


First-degree Relatives of Celiac Disease Patients Have Increased Seroreactivity to Serum Microbial Markers.

Viitasalo L, Iltanen S, Huhtala H, Saavalainen P, Kaukinen K, Lindfors K Nutrients. 2020; 12(4).

PMID: 32294897 PMC: 7230150. DOI: 10.3390/nu12041073.